Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIF18B | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | ADRB1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | ADORA2A | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
mRNA | WDR81 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | ADCK5 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | PSAT1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | KIF20A | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | PROM2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | ARHGEF25 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | EEF1E1-BLOC1S5 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |